APA (7th ed.) Citation

Xiangrong Cui, Huancheng Su, Jiaolin Yang, Xueqing Wu, Kai Huo, Xuan Jing, & Sanyuan Zhang. (2022). Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling. BMC.

Chicago Style (17th ed.) Citation

Xiangrong Cui, Huancheng Su, Jiaolin Yang, Xueqing Wu, Kai Huo, Xuan Jing, and Sanyuan Zhang. Up-regulation of MTHFD2 Is Associated with Clinicopathological Characteristics and Poor Survival in Ovarian Cancer, Possibly by Regulating MOB1A Signaling. BMC, 2022.

MLA (9th ed.) Citation

Xiangrong Cui, et al. Up-regulation of MTHFD2 Is Associated with Clinicopathological Characteristics and Poor Survival in Ovarian Cancer, Possibly by Regulating MOB1A Signaling. BMC, 2022.